Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07176988 · ClinicalTrials.gov registry record · NA
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
A NA study of Dysphonia and Primary Muscle Tension Dysphonia (MTD), sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT07176988: Recruiting NA study of Dysphonia and Primary Muscle Tension Dysphonia (MTD), sponsored by Emory University.
NCT07176988 is a NA study of Dysphonia and Primary Muscle Tension Dysphonia (MTD) that is actively recruiting participants, run by Emory University. The registered enrollment target is 120 participants, above the 45-participant average among 7 other Dysphonia trials with a reported enrollment target (167% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07176988, a NA study of Dysphonia and Primary Muscle Tension Dysphonia (MTD), is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vocal hyperfunction, also known as benign vocal fold lesions (lesions). The secondary objectives are: * To evaluate acoustic correlates of clear speech and the relationship to vocal acoustic and patient-reported voice outcomes. * To determine the association between overall dysphonia outcomes and adoption of clear speech.
Primary Outcome
The Voice Handicap Index-10 (VHI-10) is a 10-question survey used to measure how much a voice problem affects a person's daily life. Scores range from 0 to 40, with higher scores indicating a greater perceived voice handicap. Each item is rated from 0 ("never") to 4 ("always") A higher score means greater voice-related disability as perceived by the patient.
Conditions Studied
Interventions
- OTHER Hierarchical method
- OTHER Non Hierarchical method
Study Locations (1)
Georgia
- Emory Voice Center at Emory University Hospital Midtown - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2025-09-03 |
| Est. Completion | 2029-04 |
| Phase | NA |
What NCT07176988 shows while recruiting
NCT07176988 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, above the 45-participant average among 7 other Dysphonia trials with a reported enrollment target (167% higher).
The record links to 2 conditions, with Dysphonia appearing as the primary indexed condition, and to 2 interventions - of which Hierarchical method is the first listed.
NCT07176988 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07176988 about?
NCT07176988 is a clinical study titled "Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes". This research study aims to evaluate the effect of treatment delivery method on voice outcomes over 12 months in people with a primary complaint of a voice problem, diagnosed with either non-phonotraumatic vocal hyperfunction, also known as primary muscle tension dysphonia (MTD) or phonotraumatic vo...
What is the current status of trial NCT07176988?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2025-09-03. Estimated completion is 2029-04.
What conditions does trial NCT07176988 study?
This clinical trial studies the following conditions: Dysphonia, Primary Muscle Tension Dysphonia (MTD).
What interventions are being tested in trial NCT07176988?
The interventions under investigation include: Hierarchical method (OTHER), Non Hierarchical method (OTHER).
Who is sponsoring clinical trial NCT07176988?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07176988 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dysphonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
COMPLETED · NA
-
Serial Platelet-Rich Plasma Injections for Vocal Fold Atrophy, Scar, and/or Sulcus Vocalis
COMPLETED · NA
-
Silk Protein Microparticle-based Filler for Injection Augmentation
COMPLETED · NA
-
Intensive Versus Traditional Voice Therapy
COMPLETED · NA
-
Translaryngeal Vibration for Hyperfunctional Voice Disorders
RECRUITING · Phase 3
-
The Mechanism Versus PPI Trial
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI